OpenDDE turns co-folding into a scalable engine for structure prediction, design, and optimization — modeling proteins, nucleic acids, and small molecules in one all-atom system.
Modern drug discovery rarely asks about a single molecule in isolation. It asks how a candidate binds, how a complex assembles, and how to reshape that interaction toward a therapeutic goal. OpenDDE is built for exactly this: an all-atom biomolecular foundation model that co-folds every component of a system together, rather than predicting structures one chain at a time.
A single input describes the full assembly — protein chains, nucleic acids, ligands, ions, and any explicit covalent bonds — and OpenDDE resolves the joint structure at atomic resolution. The same backbone that predicts structure also drives design and optimization, turning what was a prediction tool into a scalable engine you can iterate against.
OpenDDE is not a structure predictor with a design mode bolted on. Three choices — how it reasons, how it is supervised, and how it is framed — let a single model fold, reason about, and generate biomolecular structure.
OpenDDE reasons from coarse to fine. A Pairformer-style trunk first builds residue-level single and pair representations, then expands every residue token into chemically explicit structural tokens — protein backbone and side chain, nucleic-acid backbone and base, ligand, and single atoms. Before any coordinates are generated, a structural refiner runs several rounds of latent-space reasoning over these tokens, sharpening local geometry, chemical environment, and cross-molecular interfaces up front.
Distance-only supervision such as RMSD cannot rule out steric clashes or interface gaps. OpenDDE adds a geometry-aware objective to diffusion training that scores predicted interfaces against native ones along three axes — token-level surface orientation, inter-chain spacing, and anti-clash contact quality — teaching the model the lock-and-key geometry that governs how biomolecules actually fit together.
Structure prediction and de novo design are the same conditional-denoising problem. Known-target atom masks decide the mode: leave the mask empty and OpenDDE runs unconditional prediction; fix part of the system — an antigen backbone, a target pocket — and the same model becomes a design engine. No separate generative stack, just one end-to-end model.
Across three antibody–antigen benchmarks — PXMeter-AB, FoldBench-AB and 2026ARK-AB — OpenDDE leads every model tested on success rate, under both RANK (top-1) and ORACLE (best-of-N) selection, and across all DockQ quality tiers.
Plotted against estimated training compute, OpenDDE sits on the efficient frontier of Ab-Ag performance — extracting more accuracy per token and per parameter than prior folding models, and pointing toward further gains as the recipe scales.
OpenDDE builds on ideas and components from the AlphaFold 3 ecosystem. If you use it in your work, please cite the software and the related research.